Persyst 15 EEG Review and Analysis Software— 510(k) K222002
Substantially EquivalentPersyst Development Corporation
FDA 510(k) clearance K222002 for Persyst 15 EEG Review and Analysis Software, Substantially Equivalent on 2022-12-30. Applicant: Persyst Development Corporation.
Clearance details
- Applicant
- Persyst Development Corporation
- Product code
- Code OMB
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Solana Beach, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.